Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 22;10(5):971. doi: 10.3390/biomedicines10050971

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Sublingual immunotherapy (SLIT) efficacy assessment in the whole cohort (A), in patients treated with single-allergen (Mono SLIT) and two-allergen SLIT (MIX-SLIT) (B), and with allergic rhinitis and concomitant asthma (C). MSS-0: mean symptom score at T0; MSS-12: mean symptom score at T12; MSS-24: mean symptom score at T24; ΔMSS-12 (%): percentage difference between the MSS-0 and MSS-12; ΔMSS-24 (%): percentage difference between MSS-0 and MSS-24; ns: not significant; *,**: p < 0.001; §: p < 0.05.